Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay
Andrew Morrell(Purdue University West Lafayette), Mark Cushman(University of Indianapolis), Yves Pommier(National Cancer Institute), Brian M. Fox(Purdue University West Lafayette), Alexandra Ioanoviciu(Purdue University West Lafayette), Muthusamy Jayaraman(Forma Therapeutics (United States)), Melinda G. Hollingshead(National Cancer Institute), Marintha Rae Meckley(Purdue University West Lafayette), Muthukaman Nagarajan(Purdue University West Lafayette), Smitha Antony(United States Department of Health and Human Services)
Cited by 18
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
|Nature Biotechnology|2008|1.2k